OpGen, Inc. (NASDAQ:OPGN – Get Free Report) passed below its 50 day moving average during trading on Friday . The stock has a 50 day moving average of $1.33 and traded as low as $0.59. OpGen shares last traded at $0.75, with a volume of 22,117 shares changing hands.
Analyst Ratings Changes
Separately, StockNews.com began coverage on shares of OpGen in a research report on Saturday. They issued a “sell” rating for the company.
Read Our Latest Research Report on OPGN
OpGen Stock Up 42.3 %
About OpGen
OpGen, Inc, a precision medicine company, engages in developing and commercializing molecular microbiology solutions in the United States and internationally. Its product portfolio includes Acuitas AMR Gene Panel, an in vitro diagnostic (IVD) test for the detection and identification of various bacterial nucleic acids and genetic determinants of antimicrobial resistance (AMR) from bacterial colonies isolated from any specimen, as well as Curetis CE-IVD-marked polymerase chain reaction-based SARS-CoV-2 test kits.
Further Reading
- Five stocks we like better than OpGen
- Where to Find Earnings Call Transcripts
- Cold Front, Hot Stocks: Diesel Prices Propel Energy Leaders
- How to Use High Beta Stocks to Maximize Your Investing Profits
- Sustainable and Successful: 3 Climate ETFs Beating the Market
- Stock Splits, Do They Really Impact Investors?
- Quantum Opportunity: Skywater Technology’s Long-Term Potential
Receive News & Ratings for OpGen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OpGen and related companies with MarketBeat.com's FREE daily email newsletter.
